Ulbe Holwerda
Impact in
- Clinical Biochemistry top 5%
- Metabolism and Genetic Disorders
-
- Colorectal Cancer Treatments and Studies
- Metal complexes synthesis and properties
Papers in
-
- Metabolism and Genetic Disorders 4
- Oncology 7
- Colorectal Cancer Treatments and Studies 5
- Metal complexes synthesis and properties 2
- Co-authors
- Herbert M. Pinedo (5 shared papers)Godefridus J. Peters (5 shared papers)Paul Noordhuis (5 shared papers)C.J. van Groeningen (2 shared papers)Kees Smid (2 shared papers)C.L. van der Wilt (2 shared papers)Sybren Lodewijk Meijer (1 shared paper)Wim J.F. van der Vijgh (3 shared papers)
- Journals
- Cancer Chemotherapy and Pharmacology (2 papers)Biochemical Pharmacology (1 paper)Clinical Chemistry (1 paper)Clinical Cancer Research (1 paper)Annals of Oncology (1 paper)
- Partner nations
- NetherlandsPortugalBelgium
In The Last Decade
Ulbe Holwerda
12 papers receiving 572 citations
Peers
Comparison fields: 5 of 79
- Clinical Biochemistry 91
- Oncology 140
- Pharmacology 41
- Pathology and Forensic Medicine 67
- Biomaterials 26
Countries citing papers authored by Ulbe Holwerda
This map shows the geographic impact of Ulbe Holwerda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ulbe Holwerda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ulbe Holwerda more than expected).
Fields of papers citing papers by Ulbe Holwerda
This network shows the impact of papers produced by Ulbe Holwerda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ulbe Holwerda. The network helps show where Ulbe Holwerda may publish in the future.
Co-authors
The 25 scholars most cited alongside Ulbe Holwerda, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 216 | |
| 2 | 1998 | 92 | |
| 3 | Time dependence of the selective modulation of cisplatin-induced nephrotoxicity by WR2721 in the mouse. | 1992 | 59 |
| 4 | 2003 | 45 | |
| 5 | 2000 | 41 | |
| 6 | 1991 | 38 | |
| 7 | 2015 | 28 | |
| 8 | 1992 | 25 | |
| 9 | 1995 | 23 | |
| 10 | 2004 | 18 | |
| 11 | 2004 | 6 | |
| 12 | 2017 | 4 |
About Ulbe Holwerda
Ulbe Holwerda is a scholar working on Clinical Biochemistry, Oncology, Pharmacology, Molecular Biology and Pathology and Forensic Medicine, having authored 12 papers that have together received 595 indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (5 papers), Metabolism and Genetic Disorders (4 papers), Pharmacogenetics and Drug Metabolism (3 papers), Cancer therapeutics and mechanisms (2 papers), Metal complexes synthesis and properties (2 papers), DNA and Nucleic Acid Chemistry (1 paper), Biochemical and Molecular Research (1 paper) and Gastric Cancer Management and Outcomes (1 paper). The work is most often cited by research in Clinical Biochemistry (91 citations), Oncology (140 citations), Pharmacology (41 citations), Pathology and Forensic Medicine (67 citations) and Biomaterials (26 citations). Ulbe Holwerda has collaborated with scholars based in Netherlands, Portugal and Belgium. Frequent co-authors include Herbert M. Pinedo, Godefridus J. Peters, Paul Noordhuis, C.J. van Groeningen, Kees Smid, C.L. van der Wilt, Sybren Lodewijk Meijer, Wim J.F. van der Vijgh, Marco Treskes and Isabel Tavares de Almeida. Their work appears in journals such as Cancer Chemotherapy and Pharmacology, Biochemical Pharmacology, Clinical Chemistry, Clinical Cancer Research and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.